Table 3A.
Group I+II Usual care (UC) N=271 |
Group II UC+consultations N=148 |
p-valuea | |
---|---|---|---|
Mean possesion ratiob | |||
Total of cardiovascular medication | |||
Baseline (T1) | 0.74 | 0.73 | |
After intervention (T2) | 0.93 | 0.89 | 0.08 |
Follow up of 12 months (T3) | 0.81 | 0.76 | 0.23 |
Per ATC-code | |||
Baseline (T1) | |||
Antithrombotic agents (B01) | 0.77 | 0.73 | |
Diuretics (C03) | 0.79 | 0.73 | |
Beta blocking agents (C07) | 0.87 | 0.83 | |
Calcium channel blockers (C08) | 0.95 | 0.94 | |
Agents acting angiotensin (C09) | 0.80 | 0.79 | |
Lipid modifying agents (C10) | 0.80 | 0.76 | |
After intervention (T2) | |||
Antithrombotic agents (B01) | 0.92 | 0.91 | 0.65 |
Diuretics (C03) | 0.88 | 0.82 | 0.40 |
Beta blocking agents (C07) | 0.91 | 0.91 | 0.89 |
Calcium channel blockers (C08) | 0.89 | 0.87 | 0.57 |
Agents acting angiotensin (C09) | 0.92 | 0.91 | 0.56 |
Lipid modifying agents (C10) | 0.90 | 0.89 | 0.06 |
Follow up of 12 months (T3) | |||
Antithrombotic agents (B01) | 0.86 | 0.82 | 0.27 |
Diuretics (C03) | 0.83 | 0.76 | 0.12 |
Beta blocking agents (C07) | 0.80 | 0.80 | 0.87 |
Calcium channel blockers (C08) | 0.93 | 0.91 | 0.34 |
Agents acting angiotensin (C09) | 0.84 | 0.80 | 0.48 |
Lipid modifying agents (C10) | 0.84 | 0.78 | 0.06 |
Adherentc | |||
Baseline (T1) | 53.5 | 48 | |
After intervention (T2) | 86.3 | 76.4 | 0.17 |
Follow up of 12 months (T3) | 64.9 | 76.4 | 0.38 |
Modified Morisky Scaled | |||
Baseline (T1) | |||
Low | 19.6 | 21.6 | |
Medium | 46.5 | 41.2 | |
High | 32.7 | 37.2 | |
After intervention (T2) | |||
Low | 28.7 | 31 | 0.94e |
Medium | 38 | 38.5 | |
High | 33.3 | 30.5 | |
Beliefs about medication questionnaire | |||
Necessity concern differentialf | |||
Baseline (T1) | 3.7 | 3.4 | |
After intervention (T2) | 3.8 | 3.9 | 0.86 |
Categoriesg | |||
Baseline (T1) | |||
Accepting | 27.3 | 25 | |
Ambivalent | 62.7 | 60.1 | |
Sceptical | 4.4 | 5.4 | |
Indifferent | 5.5 | 9.5 | |
After intervention (T2) | |||
Accepting | 26.6 | 32.8 | |
Ambivalent | 43.2 | 37.1 | |
Sceptical | 14.8 | 17.6 | |
Indifferent | 15.2 | 12.6 | |
Clinical outcomes | |||
Systolic blood pressure (mmHg) | |||
Baseline (T1) | 136.4 | 136.7 | |
After intervention (T2) | 155 | 155 | 0.71 |
Adherenth | 25 | 20.9 | 0.52 |
Low- density cholestrol (mmol/L) | |||
Baseline (T1) | 2.5 | 2.5 | |
After intervention (T2) | 2.2 | 2.2 | 0.74 |
Adherenti | 90.4 | 86.4 | 0.4 |
Notes: aUsual care and usual care + are combined and compared with usual care ++ group. bMean number of days dispended divided by the mean number of days between prescription refill. cPercentage of patients (%) considered adherent according to PRD total of the cardiovascular medication (PRD was above or equal to 0.8). dPercentage of patients (%) who had low, medium, or high adherent scores. eLow and medium adherence are combined and compared with high adherence group. fDifferences between concern and necessity scores (means). gPercentage of patients (%) who are classified in the four different categories of the BMQ. hPercentage of patients (%) considered adherent according to systolic blood pressure (<135 mmHg) and percentage (%) of patients using antihypertension drugs. iPercentage of patients (%) considered adherent according to LDL level (the recorded LDL level after intervention was 20% lower of baseline LDL cholesterol).